Impact of Oral Cladribine on Paramagnetic Rim Lesions in Patients with Multiple Sclerosis

被引:0
|
作者
Marrodan, Mariano [1 ]
Yanez, Paulina [2 ]
Calandri, Ismael [3 ,4 ]
Zarate, Maria [1 ]
Piedrabuena, Maria [1 ]
Fiol, Marcela [1 ]
Ysrraelit, Maria [1 ]
Correale, Jorge [1 ]
机构
[1] Fleni, Neurol, Buenos Aires, DF, Argentina
[2] Fleni, Neuroradiol, Buenos Aires, DF, Argentina
[3] Fleni, Cognit Neurol, Buenos Aires, DF, Argentina
[4] Vrije Univ Amsterdam, Alzheimer Ctr, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1449/377
引用
收藏
页码:921 / 921
页数:1
相关论文
共 50 条
  • [31] Preliminary data of paramagnetic rim lesion dynamic at 7 Tesla Magnetic Resonance Imaging in Cladribine-treated Multiple Sclerosis patients
    Dal-Bianco, Assunta
    Hametner, Simon
    Grabner, Guenther
    Lipka, Alexandra
    Krajnc, Nik
    Bsteh, Gabriel
    Kornek, Barbara
    Leutmezer, Fritz
    Trattnig, Siegfried
    Berger, Thomas
    Lassmann, Hans
    Rommer, Paulus
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 865 - 866
  • [32] The impact of paramagnetic rim lesions on cortical thickness and gray to white matter contrast in relapsing-remitting multiple sclerosis
    Xie, Yan
    Yao, Yihao
    Shen, Nanxi
    Li, Yuanhao
    Zhu, Hongquan
    Lu, Jun
    Liu, Dong
    Ding, Yujie
    Zhang, Yan
    Zhu, Wenzhen
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2024, 14 (03)
  • [33] Spatial distribution of multiple sclerosis iron rim lesions and their impact on disability
    Wittayer, Matthias
    Weber, Claudia E.
    Platten, Michael
    Schirmer, Lucas
    Gass, Achim
    Eisele, Philipp
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 64
  • [34] Development of oral cladribine for the treatment of multiple sclerosis
    Hartung, Hans-Peter
    Aktas, Orhan
    Kieseier, Bernd
    Comi, Giancarlo
    JOURNAL OF NEUROLOGY, 2010, 257 (02) : 163 - 170
  • [35] Pharmacokinetics of oral cladribine (Mylinax®) after administration in patients with multiple sclerosis
    Munafo, A
    Tran, D
    Marcus, S
    Ammoury, N
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S225 - S225
  • [36] Pharmacokinetics of oral cladribine (Mylinax®) after administration in patients with multiple sclerosis
    Munafo, A
    Tran, D
    Marcus, S
    MULTIPLE SCLEROSIS, 2005, 11 : S173 - S173
  • [37] Development of oral cladribine for the treatment of multiple sclerosis
    Hans-Peter Hartung
    Orhan Aktas
    Bernd Kieseier
    Giancarlo Comi
    Journal of Neurology, 2010, 257 : 163 - 170
  • [38] Paramagnetic rim lesions lead to pronounced diffuse periplaque white matter damage in multiple sclerosis
    Krajnc, Nik
    Schmidbauer, Victor
    Leinkauf, Joel
    Haider, Lukas
    Bsteh, Gabriel
    Kasprian, Gregor
    Leutmezer, Fritz
    Kornek, Barbara
    Rommer, Paulus Stefan
    Berger, Thomas
    Lassmann, Hans
    Dal-Bianco, Assunta
    Hametner, Simon
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (11-12) : 1406 - 1417
  • [39] Paramagnetic rim lesions as a biomarker to discriminate between multiple sclerosis and cerebral small vessel disease
    Zhu, Zhibao
    Zhang, Yuanyuan
    Li, Chun
    Guo, Wenliang
    Chen, Zhili
    Chen, Wei
    Li, Shaowu
    Wang, Ning
    Chen, Xiaochun
    Fu, Ying
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [40] Paramagnetic rim lesions are associated with peripapillary retinal nerve fiber layer thinning in multiple sclerosis
    Krajnc, N.
    Dal-Bianco, A.
    Leutmezer, F.
    Kasprian, G.
    Pemp, B.
    Kornek, B.
    Berger, T.
    Rommer, P.
    Hametner, S.
    Lassmann, H.
    Bsteh, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 187 - 187